Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-Label Safety Study of Subcutaneous Recombinant Interferon gamma-1b in Idiopathic Pulmonary Fibrosis
2004-001261-17Phase 3Completed
- Sponsor
- InterMune
- Start
- Dec 2004
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of interferon gamma-1b in idiopathic pulmonary fibrosis (IPF), sponsored by InterMune. Started Dec 2004; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on 2004-001261-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001261-17.